Ildiko Lingvay

机构：Southwestern Medical Center, The University of Texas Southwestern Medical Center · ORCID：0000-0001-7006-7401

发表论文 443 篇 · 总被引 49220 次 · h-index 92

代表论文

Semaglutide and cardiovascular outcomes by baseline and changes in adiposity measurements: a prespecified analysis of the SELECT trial (2025 · The Lancet · 被引 127)
Oral Semaglutide at a Dose of 25 mg in Adults with Overweight or Obesity (2025 · New England Journal of Medicine · 被引 113)
Once-weekly semaglutide 7·2 mg in adults with obesity and type 2 diabetes (STEP UP T2D): a randomised, controlled, phase 3b trial (2025 · The Lancet Diabetes & Endocrinology · 被引 36)
Type 2 diabetes mellitus (2026 · Nature Reviews Disease Primers · 被引 20)
Semaglutide and Hospitalizations in Patients With Obesity and Established Cardiovascular Disease (2025 · JAMA Cardiology · 被引 6)
Response to Electronic Health Record Patient Portal–Based Clinical Study Invitations (2025 · JAMA Network Open · 被引 4)